Early magnetic resonance imaging predictors of clinical progression after 48 months in clinically isolated syndrome patients treated with intramuscular interferon β-1a.
about
Neurological software tool for reliable atrophy measurement (NeuroSTREAM) of the lateral ventricles on clinical-quality T2-FLAIR MRI scans in multiple sclerosisClinical relevance of brain atrophy assessment in multiple sclerosis. Implications for its use in a clinical routine.Short-term MRI measurements as predictors of EDSS progression in relapsing-remitting multiple sclerosis: grey matter atrophy but not lesions are predictive in a real-life settingA Novel Semiautomated Pipeline to Measure Brain Atrophy and Lesion Burden in Multiple Sclerosis: A Long-Term Comparative Study.Treatment decisions in multiple sclerosis - insights from real-world observational studies.Serum lipid profile changes predict neurodegeneration in interferon-β1a-treated multiple sclerosis patients.Pathological cut-offs of global and regional brain volume loss in multiple sclerosis.Grey:white matter ratio at diagnosis and the risk of 10-year multiple sclerosis progression.Is no evidence of disease activity an achievable goal in MS patients on intramuscular interferon beta-1a treatment over long-term follow-up?A serial 10-year follow-up study of brain atrophy and disability progression in RRMS patients.Combining clinical and magnetic resonance imaging markers enhances prediction of 12-year disability in multiple sclerosis.Increased albumin quotient (QAlb) in patients after first clinical event suggestive of multiple sclerosis is associated with development of brain atrophy and greater disability 48 months later.
P2860
Q33868551-5D7B2C07-315B-4D4C-826A-A5A231DF57FAQ35997017-967298A9-5A93-4C7F-9E24-A28DFA8EF4B5Q37282063-D2F45617-BC16-4281-8FDA-1BCF1ADF225CQ38808604-419AC91C-6B6A-4EA4-AF4E-91A7B4D97BA3Q39022643-C031D1FF-3ED8-4F1B-97DB-AC85658389F7Q47924597-949CFE75-EC63-4022-8421-10C9C31B9D6EQ47967210-2417EA81-CE53-4B80-92EE-3157D11E2A41Q48257014-7283BC7E-51C3-41CB-9E09-463A79566943Q48711608-B2E634EE-ACBA-402C-A95C-C1F74B196B53Q48901292-CE18E0A5-6B21-4121-99FB-FBE5EE204E69Q52141693-93E0A861-22B9-4997-87B7-370B2E75595BQ52149416-7D163288-D830-4DB1-A8F9-60A2B8D0150F
P2860
Early magnetic resonance imaging predictors of clinical progression after 48 months in clinically isolated syndrome patients treated with intramuscular interferon β-1a.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Early magnetic resonance imagi ...... intramuscular interferon β-1a.
@en
Early magnetic resonance imagi ...... intramuscular interferon β-1a.
@nl
type
label
Early magnetic resonance imagi ...... intramuscular interferon β-1a.
@en
Early magnetic resonance imagi ...... intramuscular interferon β-1a.
@nl
prefLabel
Early magnetic resonance imagi ...... intramuscular interferon β-1a.
@en
Early magnetic resonance imagi ...... intramuscular interferon β-1a.
@nl
P2093
P2860
P50
P356
P1476
Early magnetic resonance imagi ...... intramuscular interferon β-1a
@en
P2093
D P Ramasamy
E Havrdova
J Krasensky
M Vaneckova
R Zivadinov
P2860
P304
P356
10.1111/ENE.12716
P577
2015-04-22T00:00:00Z